News | April 01, 2022
Evonik restructures health care business
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
The investment will accelerate the overall Sarclisa development program
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
he financing was significantly oversubscribed with high demand from both existing and new investors.
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
Subscribe To Our Newsletter & Stay Updated
